[{"address1": "Life Science and Technology Park", "address2": "1951 NW 7th Avenue Suite 520", "city": "Miami", "state": "FL", "zip": "33136", "country": "United States", "phone": "305 909 0840", "website": "https://longeveron.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors. It is conducting Phase 1, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joshua Michael Hare FACC, M.D.", "age": 60, "title": "Co-Founder, Chief Science Officer & Chairman", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 74000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mohamed Wa'el Ahmed Hashad", "age": 61, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 781559, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa A. Locklear M.B.A.", "age": 61, "title": "Executive VP & CFO", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 248379, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul T. Lehr J.D.", "age": 55, "title": "International Executive Director, General Counsel & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 554055, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dan  Gincel Ph.D.", "age": 52, "title": "Senior Vice President of Strategic Collaborations & Scientific Affairs", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nataliya  Agafanova M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elly  Ryu", "age": 41, "title": "VP & Corporate Controller", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.02, "open": 2.13, "dayLow": 1.62, "dayHigh": 2.18, "regularMarketPreviousClose": 2.02, "regularMarketOpen": 2.13, "regularMarketDayLow": 1.62, "regularMarketDayHigh": 2.18, "beta": 0.196, "forwardPE": -0.3045045, "volume": 492183, "regularMarketVolume": 492183, "averageVolume": 934479, "averageVolume10days": 5605750, "averageDailyVolume10Day": 5605750, "bid": 1.52, "ask": 2.08, "bidSize": 200, "askSize": 200, "marketCap": 5365243, "fiftyTwoWeekLow": 1.62, "fiftyTwoWeekHigh": 44.0, "priceToSalesTrailing12Months": 7.5673385, "fiftyDayAverage": 4.3676, "twoHundredDayAverage": 17.6805, "currency": "USD", "enterpriseValue": 927745, "floatShares": 1665745, "sharesOutstanding": 1690690, "sharesShort": 28061, "sharesShortPriorMonth": 19293, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0112, "heldPercentInsiders": 0.06711, "heldPercentInstitutions": 0.14272, "shortRatio": 0.99, "shortPercentOfFloat": 0.0301, "impliedSharesOutstanding": 3174700, "bookValue": 2.685, "priceToBook": 0.6294227, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -22211000, "trailingEps": -10.2, "forwardEps": -5.55, "lastSplitFactor": "1:10", "lastSplitDate": 1711497600, "enterpriseToRevenue": 1.309, "enterpriseToEbitda": -0.046, "52WeekChange": -0.9387681, "SandP52WeekChange": 0.23416412, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LGVN", "underlyingSymbol": "LGVN", "shortName": "Longeveron Inc.", "longName": "Longeveron Inc.", "firstTradeDateEpochUtc": 1613140200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "0810e7c7-ed9c-3408-947e-be0c34d084bb", "messageBoardId": "finmb_410711455", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.69, "targetHighPrice": 60.0, "targetLowPrice": 15.0, "targetMeanPrice": 37.5, "targetMedianPrice": 37.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 5361000, "totalCashPerShare": 2.133, "ebitda": -20060000, "totalDebt": 2041000, "quickRatio": 1.407, "currentRatio": 1.504, "totalRevenue": 709000, "debtToEquity": 30.277, "revenuePerShare": 0.326, "returnOnAssets": -0.6649, "returnOnEquity": -1.57194, "freeCashflow": -11718750, "operatingCashflow": -19002000, "revenueGrowth": -0.479, "grossMargins": 0.31171, "operatingMargins": -85.98413, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-13"}]